Sartorius Stedim (Germany) Top Insiders

56S1 Stock  EUR 183.30  1.10  0.60%   
Sartorius Stedim employs about 11.9 K people. The company is managed by 13 executives with a total tenure of roughly 87 years, averaging almost 6.0 years of service per executive, having 918.0 employees per reported executive. Examination of Sartorius Stedim's management performance can provide insight into the company performance.
Joachim Kreuzburg  Chairman
Chairman of the Board and Chief Executive Officer, Chairman of the Executive Committee
Petra Kirchhoff  President
Vice President of Corporate Communications and Investor Relations
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sartorius Stedim Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Sartorius Stedim Management Team Effectiveness

The company has return on total asset (ROA) of 0.1548 % which means that it generated a profit of $0.1548 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4143 %, meaning that it generated $0.4143 on every $100 dollars invested by stockholders. Sartorius Stedim's management efficiency ratios could be used to measure how well Sartorius Stedim manages its routine affairs as well as how well it operates its assets and liabilities.

Sartorius Stedim Workforce Comparison

Sartorius Stedim Biotech is number one stock in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is presently estimated at about 29,581. Sartorius Stedim totals roughly 11,934 in number of employees claiming about 40% of all equities under Medical Instruments & Supplies industry.
The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32.

Sartorius Stedim Biotech Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Sartorius Stedim Biotech Price Series Summation is a cross summation of Sartorius Stedim price series and its benchmark/peer.

Sartorius Stedim Notable Stakeholders

A Sartorius Stedim stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sartorius Stedim often face trade-offs trying to please all of them. Sartorius Stedim's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sartorius Stedim's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Joachim KreuzburgChairman of the Board and Chief Executive Officer, Chairman of the Executive CommitteeProfile
Petra KirchhoffVice President of Corporate Communications and Investor RelationsProfile
AnneMarie GraffinNon-Executive Independent DirectorProfile
Henri RieyNon-Executive Independent DirectorProfile
Susan DexterNon-Executive Independent DirectorProfile
Lothar KappichNon-Executive DirectorProfile
Rene FaberNon-Executive DirectorProfile
Pascale BoisselNon-Executive Independent DirectorProfile
Olivier GuitardHead BPSProfile
Heiko ImhlVP RelationsProfile
Amelie ButonNon-Executive Director, Employee RepresentativeProfile
Benedikt OrzelekInvestor Relations ContactProfile
John MackaySales MarketingProfile

About Sartorius Stedim Management Performance

The success or failure of an entity such as Sartorius Stedim Biotech often depends on how effective the management is. Sartorius Stedim management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sartorius management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sartorius management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. SARTOR STED operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8200 people.

Sartorius Stedim Workforce Analysis

Traditionally, organizations such as Sartorius Stedim use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sartorius Stedim within its industry.

Sartorius Stedim Manpower Efficiency

Return on Sartorius Stedim Manpower

Revenue Per Employee292.7K
Revenue Per Executive268.7M
Net Income Per Employee73.4K
Net Income Per Executive67.4M

Complementary Tools for Sartorius Stock analysis

When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital